Uveitis Related Cystoid Macular Edema

Ophthalmology
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

O
OculisZUG, Switzerland
1 program
1
OCS-01Phase 21 trial
Active Trials
NCT05608837Active Not RecruitingEst. Sep 2026

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
OculisOCS-01

Clinical Trials (1)

NCT05608837OculisOCS-01

Multicenter Study on the Efficacy and Safety of OCS-01 in Subjects With Uveitis Related and Post Surgical Macular Edema

Start: May 2023Est. completion: Sep 2026
Phase 2Active Not Recruiting

Related Jobs in Ophthalmology

Lead Data Manager

Genomics
Remote
8h ago

Cleanroom and Laboratory Technician

SAB BIO
9h ago

APAC Regulatory Affairs Manager

Johnson & Johnson
Singapore, Singapore
Yesterday

Clinical Operations Manager

Johnson & Johnson
Irvine, California, United States of America
Yesterday
$117K - $201K/yr

Site Delivery Leader MLL

Johnson & Johnson
Gent, East Flanders, Belgium
Yesterday

BM 喀什 PSR HY

Johnson & Johnson
Urumqi, Xinjiang, China
Yesterday

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space

Related Indications

Myopia(127)Cataract(116)Open-Angle Glaucoma(102)Glaucoma(92)Dry Eye(74)Age-Related Macular Degeneration(73)Dry Eye Disease(43)Neovascular Age-related Macular Degeneration(40)Macular Degeneration(37)Diabetic Retinopathy(25)